Concurrent Session: Extracellular Vesicles: Bench to Bedside
Saturday, September 9, 2023 03:15 PM - 04:15 PM
Grand Ballroom L
Chair
Elani Wiest, PhD, Center for Regenerative Biotherapeutics, USA
Speakers
Bruna Corradetti, PhD, Baylor College of Medicine, USA – Exosomes as reconfigurable delivery systems: advantages and pitfalls for therapeutic applications
Honami Naora, PhD, MD Anderson, USA – Identification of miRNA-enriched extracellular vesicles that derive from cancer cells: Implications for liquid biopsy
Elani Wiest, PhD, Center for Regenerative Biotherapeutics, USA – Developing a platform to manufacture cGMP-grade MSCs and EVs simultaneously for clinical applications
Olesia Gololobova, MEng, PhD, Johns Hopkins University, USA – Unveiling Extracellular Vesicle Small RNA Biomarkers for Early Prediction of Alzheimer’s Disease: Insights from Brain and Plasma
Session Objectives
Elani Wiest, PhD, Center for Regenerative Biotherapeutics, USA
Speakers
Bruna Corradetti, PhD, Baylor College of Medicine, USA – Exosomes as reconfigurable delivery systems: advantages and pitfalls for therapeutic applications
Honami Naora, PhD, MD Anderson, USA – Identification of miRNA-enriched extracellular vesicles that derive from cancer cells: Implications for liquid biopsy
Elani Wiest, PhD, Center for Regenerative Biotherapeutics, USA – Developing a platform to manufacture cGMP-grade MSCs and EVs simultaneously for clinical applications
Olesia Gololobova, MEng, PhD, Johns Hopkins University, USA – Unveiling Extracellular Vesicle Small RNA Biomarkers for Early Prediction of Alzheimer’s Disease: Insights from Brain and Plasma
Session Objectives
- Identify (and overcome) potential limitations in developing exosome-based therapeutics for clinical applications.
- Describe the challenges associated with manufacturing cGMP-grade EVs for clinical applications.
- Understand why RNAs are valuable biomarkers for disease prediction.
